コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ough a c12-gp130 complex; it did not use the LIF receptor.
2 SM receptor; human OSM instead activates the LIF receptor.
3 s PBEF via its OSM receptor beta and not its LIF receptor.
4 tenuated by immuneutralization of either the LIF receptor (35%, P<0.05) or the gp130 affinity convert
6 estigated the interaction between CT-1/gp130/LIF receptor and ET-1/endothelin type A (ET(A)) receptor
13 TF, and CT-1 act through the known receptors LIF receptor beta (LIFRbeta) and gp130 and well defined
14 3T3 cells (which endogenously express gp130, LIF receptor beta [LIFRbeta], and the protein product, c
15 n M and ciliary neurotrophic factor, and the LIF receptor beta and glycoprotein gp130 in normal human
18 RG cells express leukemia-inhibitory factor (LIF) receptors during neurogenesis, and consistent with
19 ed to upregulate leukemia inhibitory factor (LIF) receptor, epidermal growth factor-like transforming
21 uterus increased HLA-G, EGF-Receptor-2, and LIF-Receptor expression on EVT, presumably representing
22 f mice carrying a targeted disruption of the LIF receptor gene, a common component of the receptor co
23 sociated signal-transducing component of the LIF receptor, gp130, is also expressed in both the lumin
24 t sortilin is essential for co-activation of LIF receptor/gp130 signaling in BECs, but not for IL-6 s
29 keletal muscles, we examined whether the LIF-LIF receptor (LIF-R) axis affects the biology of rhabdom
30 -6 promoter after fibroblast activation, and LIF receptor (LIFR) and STAT4 formed a molecular complex
31 (LIF, OSM, CNTF, and CT-1) also utilize the LIF receptor (LIFR) as a component of their receptor com
32 tes giant cell differentiation in vitro, and LIF receptor (LIFR) deficiency results in loss of giant
33 he hypothesis that the reduced expression of LIF receptor (LIFR) observed in hepatoma cells is mediat
34 LIF/OSM receptor (a heterodimer of gp130 and LIF receptor (LIFR)) and the OSM-specific receptor (a he
35 d murine LIF (mLIF) act in mouse cells via a LIF receptor (LIFR)-glycoprotein 130 (gp130) heterodimer
37 weeks with a monoclonal antibody against the LIF receptor motif, gp130 (0.833 mg ml-1) (P < 0.05, Man
38 cells, we hypothesized that LIF binds to the LIF receptor on AC6.21 stromal cells, leading to up-regu
39 n130 (gp130) and leukemia inhibitory factor (LIF) receptor, on cardiac fibroblast growth in cultured